(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -2.84% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.28%.
Pfizer's revenue in 2026 is $62,785,000,000.On average, 27 Wall Street analysts forecast PFE's revenue for 2026 to be $350,660,327,562,048, with the lowest PFE revenue forecast at $331,903,178,348,000, and the highest PFE revenue forecast at $374,642,642,016,384. On average, 23 Wall Street analysts forecast PFE's revenue for 2027 to be $339,971,197,364,288, with the lowest PFE revenue forecast at $318,325,708,713,824, and the highest PFE revenue forecast at $374,182,099,704,672.
In 2028, PFE is forecast to generate $326,678,013,107,712 in revenue, with the lowest revenue forecast at $283,767,978,212,768 and the highest revenue forecast at $372,555,987,344,800.